Live from the NIH registry
Studies recruiting near Pasadena right now
Top 25 of 3,007 recruiting studies, sorted by proximity — each links to its official registry page
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11
Phase 2
Interventional 270 participants sought
M D Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: National Cancer Institute (NCI)
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
Lymphedema, Fibrosis
Phase 2
Interventional 295 participants sought
MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Baylor College of Medicine — Houston, Texas (14.7 mi)
· Sponsor: Westat
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Houston, Texas (14.7 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina Consultants of Texas-Bellaire-67493 — Bellaire, Texas (18.8 mi)
· Sponsor: Boehringer Ingelheim
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
Hematopoietic and Lymphoid Cell Neoplasm, Steroid Refractory Graft Versus Host Disease
EARLY/Phase 1
Interventional 24 participants sought
M D Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 83 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
Human Papillomavirus
N/A
Observational 600 participants sought
MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 24 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
Obesity and Diabetes Mellitus, Type 2, Diabetes Prevention
N/A
Interventional 30 participants sought
Children's Nutrition Research Center — Houston, Texas (14.7 mi)
· Sponsor: Baylor College of Medicine
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Houston, Texas (14.7 mi)
· Sponsor: AstraZeneca
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Phase 2
Interventional 30 participants sought
Research Site — Houston, Texas (14.7 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
IDH1 wt Allele, Recurrent Anaplastic Astrocytoma
Phase 1
Interventional 36 participants sought
M D Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Texas Children's Hospital — Houston, Texas (14.7 mi)
· Sponsor: Nationwide Children's Hospital
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
Obesity and Type 2 Diabetes
N/A
Interventional 40 participants sought
USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine — Houston, Texas (14.7 mi)
· Sponsor: Baylor College of Medicine
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Phase 1
Interventional 600 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: Erasca, Inc.
Stem Cells for Erectile Dysfunction Post RALP
Erectile Dysfunction, Prostate Cancer
Phase 1, Phase 2
Interventional 40 participants sought
Houston Methodist — Houston, Texas (14.7 mi)
· Sponsor: The Methodist Hospital Research Institute
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Houston — Houston, Texas (14.7 mi)
· Sponsor: RAI Services Company
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 120 participants sought
Accurate Clinical Management LLC — Houston, Texas (14.7 mi)
· Sponsor: Hoffmann-La Roche
BreEStim for Motor Recovery in Chronic Stroke With Moderate Impairment After a Long-term Use (Pilot).
Motor Recovery
N/A
Interventional 4 participants sought
The University of Texas Health Science Center — Houston, Texas (14.7 mi)
· Sponsor: The University of Texas Health Science Center, Houston
Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation
Allogeneic Transplantation
N/A
Observational 1,200 participants sought
MD Anderson Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: M.D. Anderson Cancer Center
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Baylor College of Medicine — Houston, Texas (14.7 mi)
· Sponsor: Jaeb Center for Health Research
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Houston, Texas (14.7 mi)
· Sponsor: Sameek Roychowdhury
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Houston Methodist Hospital Cancer Center — Houston, Texas (14.7 mi)
· Sponsor: Relay Therapeutics, Inc.